Industry Experience

Jodi’s background as in-house counsel for an international contract research firm makes her adept at helping clients navigate contract matters for clinical trials, especially when it comes to international studies. She handles clinical trial and related agreements involving complex issues with multiple stakeholders, as well as sponsor-CRO and master services agreements for life sciences clients. Jodi also advises clients on licensing matters and on standardized agreement terms.

experience +

experience –

Prior to joining the firm, Jodi worked as senior legal counsel for PSI CRO AG, a global contract research organization. As in-house counsel, she worked with internal teams and pharmaceutical and medical device clients to conclude clinical trial and related agreements in countries all over the world. Additionally, Jodi managed internal compliance issues, training and advised on general legal issues.

Jodi started her legal career as a commercial litigation Associate at Morgan Lewis & Bockius LLP where she represented clients on a number of complex commercial matters.

Recent Client Work +

Recent Client WOrk –

  • Drafted clinical trial related agreements and advised on clinical trial related matters in connection with Atara Biotherapeutics Inc.’s licensing of certain T-cell therapies from Memorial Sloan Kettering Cancer Center
  • Lead Attorney for certain Civitas Therapeutics, Inc. studies of a Parkinson Disease therapy, including a phase III U.S./Canada study and its extension (approximately 50 sites) and the European segment of a phase III worldwide study (approximately 70 ex-U.S. sites)
  • Lead Attorney for the U.S. portion of a phase III breast cancer therapy study run by Puma Biotechnologies, Inc. (approximately 40 sites)
  • ‍Negotiated numerous ex-US agreements, including a Reciprocal Confidentiality Agreement and Investigator-initiated Research Agreement, for a U.S. client (Puma) in connection with an Investigator-Initiated Study sponsored by a large healthcare organization in England
  • Negotiated an in-licensing agreement with an ex-US biopharmaceutical company for Regentis' use and access right to the results of a multi-center clinical study (involving joint regeneration therapy)
  • Analyzed multiple clients’ (Neon, Promedior) obligations under agreements with their collaborators and suppliers and advise on recommended changes to clinical trial agreement templates in light of such obligations

Community +

Community –

Bar Admissions
  • California
  • ‍University of California, Davis School of Law, J.D.
  • San Jose State University, B.S., summa cum laude